Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MBD4 mutation
i
Other names:
MBD4, Methyl-CpG Binding Domain 4, DNA Glycosylase, Methyl-CpG-Binding Domain Protein 4, Mismatch-Specific DNA N-Glycosylase, Methyl-CpG Binding Domain Protein 4, Methyl-CpG-Binding Endonuclease 1, Methyl-CpG-Binding Protein MBD4, MED1, G/5-Fluorouracil Mismatch Glycosylase With Biphasic Kinetics, Putative Methyl-CpG Binding Protein, 3,N(4)-Ethenocytosine Glycosylase, G/T Mismatch Glycosylase, G/U Mismatch Glycosylase
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
8930
Related biomarkers:
Mutation
CNA
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MBD4 mutation
Uveal Melanoma
MBD4 mutation
Uveal Melanoma
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
MBD4 mutation
Uveal Melanoma
MBD4 mutation
Uveal Melanoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
MBD4 mutation
Uveal Melanoma
MBD4 mutation
Uveal Melanoma
pembrolizumab
Sensitive: C4 – Case Studies
pembrolizumab
Sensitive
:
C4
pembrolizumab
Sensitive: C4 – Case Studies
pembrolizumab
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.